PMID- 32256098 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240328 IS - 1178-7007 (Print) IS - 1178-7007 (Electronic) IS - 1178-7007 (Linking) VI - 13 DP - 2020 TI - Phocea, Pseudoflavonifractor and Lactobacillus intestinalis: Three Potential Biomarkers of Gut Microbiota That Affect Progression and Complications of Obesity-Induced Type 2 Diabetes Mellitus. PG - 835-850 LID - 10.2147/DMSO.S240728 [doi] AB - PURPOSE: The purpose of this study was to explore the difference and association between intestinal microbiota and plasma metabolomics between type 2 diabetes mellitus (T2DM) and normal group and to identify potential microbiota biomarkers that contribute the most to the difference in metabolites. METHODS: Six male ZDF model (fa/fa) rats were fed by a Purina #5008 Lab Diet (crude protein 23.5%, crude fat 6.5%) for 3 weeks and their age-matched 6 ZDF control (fa/+) rats were fed by normal rodent diet. Their stool and blood samples were collected at 12 weeks. To analyze the microbial populations in these samples, we used a 16S rRNA gene sequencing approach. Liquid chromatography-mass spectrometry (LC-MS) followed by multivariate statistical analysis was applied to the plasma metabolites profiling. Correlation analysis of them was calculated by Pearson statistical method. RESULTS: Twelve potential biomarkers of intestinal microbial flora and 357 differential metabolites were found in ZDF fa/fa rats, among which there are three flora that contributed the most to the perturbation of metabolites, including genus Phocea, Pseudoflavonifractor and species Lactobacillus intestinalis. CONCLUSION: Our study demonstrates the alterations of the abundance and diversity of the intestinal microbiota and the perturbation of metabolites in ZDF rats (fa/fa). We found three potential biomarkers of intestinal microbiota that may lead to perturbation in plasma metabolites. This may prompt new pathogenesis of obesity-related T2DM, but we also need to study further about the causal relationship between intestinal microbe and T2DM, so as to find the target of T2DM treatment or preventive measures. CI - (c) 2020 Wang et al. FAU - Wang, Yuxin AU - Wang Y AUID- ORCID: 0000-0003-2101-413X AD - Department of Physical and Chemical Inspection, School of Public Health, Shandong University, Jinan, Shandong 250012, People's Republic of China. FAU - Ouyang, Meishuo AU - Ouyang M AD - Department of Public Health, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan. FAU - Gao, Xibao AU - Gao X AD - Department of Physical and Chemical Inspection, School of Public Health, Shandong University, Jinan, Shandong 250012, People's Republic of China. FAU - Wang, Shuai AU - Wang S AD - Institute of Toxicology, School of Public Health, Shandong University, Jinan, Shandong 250012, People's Republic of China. FAU - Fu, Chunyang AU - Fu C AD - Department of Physical and Chemical Inspection, School of Public Health, Shandong University, Jinan, Shandong 250012, People's Republic of China. FAU - Zeng, Jiayi AU - Zeng J AD - Department of Physical and Chemical Inspection, School of Public Health, Shandong University, Jinan, Shandong 250012, People's Republic of China. FAU - He, Xiaodong AU - He X AD - Department of Physical and Chemical Inspection, School of Public Health, Shandong University, Jinan, Shandong 250012, People's Republic of China. AD - Shandong Provincial Key Laboratory of Infection and Immunity, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, People's Republic of China. LA - eng PT - Journal Article DEP - 20200319 PL - New Zealand TA - Diabetes Metab Syndr Obes JT - Diabetes, metabolic syndrome and obesity : targets and therapy JID - 101515585 PMC - PMC7090210 OTO - NOTNLM OT - 16S rRNA sequencing OT - Zucker diabetic fatty rats OT - intestinal microbiota OT - plasma metabolomics OT - type 2 diabetes mellitus COIS- Yuxin Wang, Xibao Gao, Chunyang Fu, and Xiaodong He report grants from Ministry of Education of the People's Republic of China and People's Government of Shandong Province during the conduct of the study. The authors report no other conflicts of interest in this work. EDAT- 2020/04/08 06:00 MHDA- 2020/04/08 06:01 PMCR- 2020/03/19 CRDT- 2020/04/08 06:00 PHST- 2019/12/02 00:00 [received] PHST- 2020/02/29 00:00 [accepted] PHST- 2020/04/08 06:00 [entrez] PHST- 2020/04/08 06:00 [pubmed] PHST- 2020/04/08 06:01 [medline] PHST- 2020/03/19 00:00 [pmc-release] AID - 240728 [pii] AID - 10.2147/DMSO.S240728 [doi] PST - epublish SO - Diabetes Metab Syndr Obes. 2020 Mar 19;13:835-850. doi: 10.2147/DMSO.S240728. eCollection 2020.